Chapter 14.4
Hepatic Toxicity Induced by Herbal Medicines
Felix Stickel,
Detlef Schuppan,
Felix Stickel
Search for more papers by this authorDetlef Schuppan
Search for more papers by this authorFelix Stickel,
Detlef Schuppan,
Felix Stickel
Search for more papers by this authorDetlef Schuppan
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Kessler RC Davis RB Foster DF et al. (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135, 262–268.
- Strader DB Bacon BR Lindsay KL et al. (2002) Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 97, 2391–2397.
- Flora KD Rosen HR Brenner KG et al. (1996) The use of neuropathic remedies for chronic liver disease. Am J Gastroenterol 91, 2654–2655.
- Estes JD Stolpman D Olyaei A et al. (2003) High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 138, 852–858.
- M Blumenthal (ed.) (1998) The Complete German Commission E Monographs – Therapeutic Guide to Herbal Medicines. Austin, TX: American Botanical Council.
- Anon (2002) Licensing of Medicines: Policy on Herbal Medicines. Herbal Safety News. London: Medicines Control Agency (http://www.mca.gov.uk/ourwork/licensingmeds/herbalsafety.htm)(.
- De Smet PAGM (2002) Herbal remedies. N Engl J Med 347, 2046–2056.
- Stedman C (2002) Herbal hepatotoxicity. Semin Liver Dis 22, 195–206.
- Chen TSN Chen PS (1998) Liver in traditional Chinese medicine. J Gastroenterol Hepatol 13, 437–442.
-
Woolf GM
Petrovic LM
Rojter SE et al.
(1994)
Acute hepatitis associated with the Chinese herbal product Jin Bu Huan.
Ann Intern Med
10,
729–735.
10.7326/0003-4819-121-10-199411150-00001 Google Scholar
- Picciotto A Campo N Brizzolara R et al. (1998) Chronic hepatitis induced by Jin Bu Huan. J Hepatol 28, 165–167.
- Nadir A Agrawal S King PD et al. (1996) Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang. Am J Gastroenterol 91, 1436–1438.
- Bajaj J Knox JF Komorowski R et al. (2003) The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci 48, 1925–1928.
- Kane JA Kane SP Jain S et al. (1995) Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 36, 146–147.
- Yoshida EM McLean CA Cheng ES et al. (1996) Chinese herbal medicine, fulminant hepatitis and liver transplantation. Am J Gastroenterol 12, 2647–2648.
- Galloway JH Marsh ID Bittiner SB et al. (1991) Chinese herbs for eczema, the active compound. Lancet 337, 566.
- But PP Tomlinson B Lee KL et al. (1996) Hepatitis related to the Chinese medicine Shou-wu-pian manufactured fro. Polygonum multiflorum. Vet Hum Toxicol 38, 280–282.
- Park GJH Mann SP Ngu MC et al. (2001) Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived fro. Polygonum multiflorum. J Gastroenterol Hepatol 16, 115–117.
-
Westendorf J
(1993)
Anthranoid derivatives — general discussion. In:
PAGM De Smet,
K Keller,
R Hansel Chandler (eds)
Adverse Effects of Herbal Drugs.
Berlin:
Springer,
pp. 105–118.
10.1007/978-3-642-48906-8_3 Google Scholar
- Kanda T Yokosuko O Okada O et al. (2003) Severe hepatotoxicity associated with Chinese diet product Onshidou-Genbi-Kounou. J Gastroenterol Hepatol 18, 354–355.
- Lin TJ Tsai MS Chiou MN et al. (2002) Hepatotoxicity caused b. Breynia officinalis. Vet Hum Toxicol 44, 87–88.
- Stickel F Seitz HK (2000) The efficacy and safety of comfrey. Pub Health Nutr 3 (4A), 501–508.
- Stillman AE Huxtable RJ Fox D et al. (1977) Hepatic veno-occlusive disease due to pyrrolizidin. (Senecio) poisoning in Arizona. Gastroenterology 73, 349–352.
- Fox DW Hart MC Bergeson PS et al. (1978) Pyrrolizidin. (Senecio) intoxication mimicking Reye's syndrome. J Pediatr 93, 980–982.
- Weston CF Cooper BT Davis JD et al. (1987) Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br Med J 295, 183.
- Roulet M Laurini R Rivier L et al. (1988) Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea. J Pediatr 112, 433–436.
- DeLeve LD Shulman HM McDonald GB et al. (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22, 27–42.
- Mattocks AR (1986) Chemistry and Toxicology of Pyrrolizidine Alkaloids. London: Academic Press.
- Willett KL Roth RA Walker L et al. (2004) Workshop overview: hepatotoxicity assessment for botanical dietary supplements. Toxicol Sci 79, 4–9.
- Larrey D Vial T Pawels A et al. (1992) Hepatitis after germande. (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 117, 129–132.
- Larrey D Pageaux GP (1995) Hepatotoxicity of herbal remedies and mushrooms. Semin Liver Dis 15, 183–188.
- Kouzi SA McMurtry RJ Nelson SD et al. (1994) Hepatotoxicity of germande. (Teucrium chamedrys L.) and one of its constituent neoclerodane diterpenes, teucrin A in the mouse. Chem Res Toxicol 7, 850–856.
- Loeper J Descatoire V Letteron P et al. (1994) Hepatotoxicity of germander in mice. Gastroenterology 106, 464–472.
- Lekehal M Pessayre D Lerreau JM et al. (1996) Hepatotoxicity of the herbal medicine, germander. Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 24, 212–218.
- Fau D Lekehal M Farrell G et al. (1997) Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 113, 1334–1346.
- Mattei A Rucai P Samuel D et al. (1995) Liver transplantation for severe acute liver failure after herbal medicin. (Teucrium polium) administration. J Hepatol 22, 597.
- Colombo ML Bosisio E (1996) Pharmacological activities o. Chelidonium majus L.(Papaveraceae). Pharmacol Res 33, 127–134.
- Strahl S Ehret V Dahm HH et al. (1998) Necrotizing hepatitis after taking herbal medication extracts of kava or of common or lesser celandine (article in German). Dtsch Med Wschr 123, 1410–1414.
- Greving I Meister V Monnerjahn C et al. (1998) Chelidonium majus:a rare reason for severe hepatotoxic reaction. Pharmaepidemiol Drug Safety 7, S66–69.
- Benninger J Schneider HT Schuppan D et al. (1999) Acute hepatitis induced by greater celandin (Chelidonium majus). Gastroenterology 117, 1234–1237.
- Stickel F Poschl G Seitz HK et al. (2003) Acute hepatitis induced by greater celandine. Scand J Gastroenterol 38, 565–568.
- Davies LP Drew CA Duffield P et al. (1992) Kavapyrones and resin: studies on GABA., GABAB and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 71, 120–126.
- Pittler MH Ernst E (2000) Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol 20, 84–89.
- Aithal GP Rawlins MD Day CP et al. (2000) Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reaction. J Hepatol 33, 949–952.
- Stickel F Baumuller HM Seitz K et al. (2003) Hepatitis induced by kava-kav. (Piper methysticum rhizoma). J Hepatol 39, 62–67.
- Russmann S Lauterburg BH Helbling A et al. (2001) Kava hepato-toxicity. Ann Intern Med 135, 68–69.
- Centers for Disease Control and Prevention (2003) Hepatic toxicity possibly associated with kava-containing products — United States, Germany, and Switzerland. JAMA 289, 36–37.
- Currie BJ Clough AR (2003) Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use. Med J Aust 178, 421–422.
- Nerurkar PV Dragull K Tang CS et al. (2004) In vitro toxicity of kava alkaloid, pipermethystine, in Hep G2 cells compared to kavalactones. Toxicol Sci 79, 106–111.
- Kassler WJ Blanc P Greenblatt R et al. (1991) The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 151, 2281–2288.
- Sheikh NM Philen RM Love LA et al. (1997) Chaparral-associated hepatotoxicity. Arch Intern Med 157, 913–919.
- Agarwal R Wang ZY Bik DP et al. (1991) Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 19, 620–624.
- Larrey D (1997) Hepatotoxicity of herbal remedies. J Hepatol 26, 47–54.
- Popat A Shear NH Malkiewicz I et al. (2001). The toxicity of Callilepsis laureola, a South African traditional herbal medicine. Clin Biochem 34, 229–236.
- Stewart MJ Steenkamp V (2000) The biochemistry and toxicity of atractyloside: a review. Ther Drug Monit 22, 641–649.
- Popat A Shear NH Malkiewicz I et al. (2002) Mechanism of Impil. (Callilepsis laureola)-induced cytotoxicity in Hep G2 cells. Clin Biochem 35, 57–64.
- Beuers U Spengler U Pape GR et al. (1991) Hepatitis after chronic abuse of senna. Lancet 337, 372–373.
- Popper H Rubin E Cardiol D et al. (1965) Drug-induced liver disease: a penalty for progress. Arch Intern Med 115, 128–136.
- Nadir A Reddy T Van Thiel DH et al. (2000) Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am J Gastroenterol 95, 3634–3637.
- Anderson IB Mullen WH Meeker JE et al. (1996) Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 124, 726–734.
- Thomassen D Slattery JT Nelson SD et al. (1990) Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione. J Pharmacol Exp Ther 253, 567–572.
- Thomassen D Knebel N Slattery JT et al. (1992) Reactive intermediates in the oxidation of menthofuran by cytochromes P-450. Chem Res Toxicol 5, 123–130.
- Hamid S Rojter S Vierling J et al. (1997) Protracted cholestatic hepatitis after the use of prostata. Ann Intern Med 127, 169.
- Chauhan BL Kulkarni RD (1991) Effect of LIV.52, a herbal preparation, on absorption and metabolism of ethanol in humans. Eur J Clin Pharmacol 40, 189–191.
- Fleig WW and a European multicenter study group (1997). The ayurvedic drug LIV.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial (abstract). J Hepatol 26 (Suppl.1), 127.
- Favreau JT Ryu ML Braunstein G et al. (2002) Severe hepatotoxicity associated with the dietary supplement Lipo Kinetix. Ann Intern Med 136, 590–595.
- Abo-Khatwa AN Al-Robai AA Al-Jawhari DA et al. (1996) Lichen acids as uncouplers of oxidative phosphorylation of mouse-liver mitochondria. Natural Toxins 4, 96–102.
- Bagheri H Brue P Lacroix I et al. (1998) Fulminant hepatic failure after herbal medicine ingestion in children. Thérapie 53, 77–83.
- Brinkhaus B Lindner M Schuppan D et al. (2000) Chemical, pharmacological and clinical profile of the East Asian plan. Centella asiatica. Phytomedicine 7, 427–448.
- Jorge OA Jorge AD (2005) Hepatotoxicity associated with the ingestion o. Centella asiatica. Rev Esp Enferm Dig 97, 115–124.
- Millonig G Stadelmann S Vogel W et al. (2005) Herbal hepatotoxicity: acute hepatitis caused by a Noni preparatio. (Morinda citrifolia). Eur J Gastroenterol Hepatol 17, 45–47.
- Lucena MI Camargo R Andrade RJ et al. (2001) Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 33, 123–130.
